drugset / Trial / NCT07415018
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease
NaSingle-groupOpen-labelDiagnostic
Summary
To learn if gadopiclenol (a contrast agent) used during MRI scanning can help in the detection of early LMD.
Timeline
- Start
- 2026-06-10
- Primary completion
- 2027-07-31
- Completion
- 2029-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadopiclenol | Diagnostic / imaging agent | — | Intravenous |
| Background | Gadobutrol | Diagnostic / imaging agent | — | Intravenous |